Miami, FL, June 10, 2026 (GLOBE NEWSWIRE) — Tecnoglass, Inc. (NYSE: TGLS) (“Tecnoglass” or the “Company”), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced that its Board of Directors has declared a quarterly dividend of $0.15 per share, or $0.60 per share on an annualized basis, for the second quarter of 2026. Shareholders of record as of the close of business on June 30, 2026 will be paid a dividend of $0.15 on July 31, 2026. About TecnoglassTecnoglass Inc. is a leading producer of high-end aluminum and vinyl windows and architectural glass serving the multi-family, single-family, and commercial end markets. Tecnoglass is the second largest glass fabricator serving the U.S. and the #1 architectural glass...

SINGAPORE, June 10, 2026 (GLOBE NEWSWIRE) — Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), a medical clinic operator in Singapore, today announced that the Company’s board of directors has approved the consolidation of the Company’s issued and outstanding shares of the Company on a 1-for-12 ratio with the marketplace effective date of June 22, 2026. The objective of the reverse share split is to enable the Company to recomply with Nasdaq Marketplace Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1 per share. According to the law of the British Virgin Islands, the jurisdiction of the Company’s incorporation, and its memorandum and articles of association, no approval by shareholders and no amendment of the Company’s articles of association will be required for the reverse share split. Beginning...

VERKAZIA is now supported by a comprehensive commercial strategy focused on physician education, patient access, and affordability initiatives to ensure dependable supply and remove access barriers VERKAZIA is indicated for the treatment of all forms of vernal keratoconjunctivitis (VKC), a serious allergic eye disease that primarily affects children and may lead to sight-threatening conditions if left untreated or undertreated VERKAZIA is a calcineurin inhibitor immunomodulator that targets the underlying inflammatory mechanisms of VKC and may reduce the need for steroid rescue, all of which are associated with risks such as glaucoma or cataract formationNASHVILLE, Tenn., June 10, 2026 (GLOBE NEWSWIRE) — Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the...

Strategic agreement builds on more than 15 years of global partnership and supports L’Oréal’s dynamic growth across Central Europe WARSAW, Poland, June 10, 2026 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, announced today that it has signed a multi-year agreement with L’Oréal to support the beauty leader’s logistics operations in Europe. The partnership will strengthen L’Oréal’s supply chain capabilities across Czechia, Slovakia and Hungary, supporting growth in both retail and e‑commerce channels. The agreement builds on a long‑standing global relationship between GXO and L’Oréal, spanning more than 15 years in the United States and Mexico. Drawing on a proven track record of success, GXO was selected to support L’Oréal’s strategic decision to outsource its logistics...

JUPITER, Fla., June 10, 2026 (GLOBE NEWSWIRE) — Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will host an Investor Day in New York City on Tuesday, December 8, 2026 at 10:30 a.m. Eastern time at the Harvard Club. The event will include presentations from Ligand’s senior management team highlighting the company’s strategy, recent investment activity, royalty portfolio, and long-term financial outlook. A live webcast of the event will be accessible through Ligand’s Investor Relations website at investor.ligand.com. A detailed agenda, including dial-in information, will be provided closer to the event. About Ligand Ligand is a leading royalty aggregator, partnering with biopharmaceutical companies to finance and advance late-stage clinical development programs. Ligand owns and manages one of the largest...

BETHESDA, Md., June 10, 2026 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that Gene Mack, President and CEO, will participate in a virtual fireside chat and one-on-one meetings at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit, being held in a hybrid format from June 15-16, 2026. Fireside Chat Details Date and Time: Monday, June 15, 2026; replay beginning 7:00 a.m. EDT Access a replay of the fireside chat here or visit the “Investors & Media/News & Events” section of the Company’s website at https://gaintherapeutics.com. Registered attendees can request one-on-one meetings with Gain management via H.C. Wainwright....

Government Officials Highlight Troilus’ Role in Advancing Québec’s Critical Minerals Strategy and Economic Development Priorities MONTREAL, June 10, 2026 (GLOBE NEWSWIRE) — Troilus Mining Corp. (TSX: TLG; OTCQX: CHXMF; FSE: CM5) (“Troilus” or the “Company”) is pleased to announce that it recently welcomed representatives from the Government of Québec to the Troilus Copper-Gold Project in north-central Québec for the official announcement of the allocation of 70 megawatts (“MW”) of hydroelectric power to the Project (see June 2, 2026 press release). The announcement, held at the Troilus Project site on June 8, 2026, was made by Bernard Drainville, Minister of Economy, Innovation and Energy (“MEIE”), and Kateri Champagne Jourdain, Minister of Natural Resources and Forests (“MRNF”), alongside Denis Lamothe, Member of the...

BROOMFIELD, Colo., June 10, 2026 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms through its Nociscan® platform to help physicians identify the location of chronic low back pain and support improved treatment success rates, today announced that it will be presenting at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub on Wednesday, June 17, 2026 at 8:30 AM PT at the Bellagio Resort & Hotel. Jeff Thramann, Executive Chairman, will be hosting the presentation and answering questions at the conclusion. Recent Key HighlightsTriple-digit annual growth signals accelerating Nociscan adoption and integration into clinical workflows Advancing reimbursement and...

EL MONTE, Calif., June 10, 2026 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that Erica Wei, its Chief Financial Officer, and Iman Schrock, its President, will present at the virtual Sidoti Small Cap Conference on Wednesday, June 17, 2026, at 11:30 a.m. ET/8:30 a.m. ET. The presentation will be webcast live at https://investors.gigacloudtech.com/news-events/events, and will be available for replay for 90 days after the event ends. GigaCloud also will conduct one-on-one meetings with investors throughout the day. To schedule a meeting, please contact your Sidoti representative, or PondelWilkinson at tkehrli@pondel.com. About GigaCloud Technology Inc GigaCloud Technology Inc is a pioneer...